Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Thrombosis Journal
Published in: Thrombosis Journal 1/2021

Open Access 01-12-2021 | Venous Thrombosis | Correction

Correction to: Thrombosis and bleeding outcomes in the treatment of cerebral venous thrombosis in cancer

Authors: Nadia I. Abelhad, Wei Qiao, Naveen Garg, Cristhiam M. Rojas-Hernandez

Published in: Thrombosis Journal | Issue 1/2021

Login to get access

Excerpt

Correction to: Thrombosis J 19, 37 (2021) …
Literature
1.
Metadata
Title
Correction to: Thrombosis and bleeding outcomes in the treatment of cerebral venous thrombosis in cancer
Authors
Nadia I. Abelhad
Wei Qiao
Naveen Garg
Cristhiam M. Rojas-Hernandez
Publication date
01-12-2021
Publisher
BioMed Central
Published in
Thrombosis Journal / Issue 1/2021
Electronic ISSN: 1477-9560
DOI
https://doi.org/10.1186/s12959-021-00300-y

Other articles of this Issue 1/2021

Thrombosis Journal 1/2021 Go to the issue

Research

Viscoelastometry for detecting oral anticoagulants

Case report

Nonnegligible causes of symptoms of acute lower extremities——3 cases of May-Thurner syndrome with deep vein thrombosis

Research

Prevalence and risk factors of thrombotic events on patients with COVID-19: a systematic review and meta‐analysis

Research

Temporal change in Syndecan-1 as a therapeutic target and a biomarker for the severity classification of COVID-19

Case report

Thrombotic antiphospholipid syndrome in a child with human immunodeficiency virus: a rare case report

Research

Prevalence, risk, and outcome of deep vein thrombosis in acute respiratory distress syndrome
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits